| Website | transmedics.com/w... |
| @TransMedicsInc | |
| Category | BioTech |
| Phone | 978.552.0900 |
| info@transmedics.com | |
| Employees | |
| Founded | 1998 |
| Description | Living Organ Transplants |
| TOTAL | $131M |
| FUNDING TOTAL | $131M |
| Series B, 1/04 Flagship Ventures 3i Group CB Health Ventures Sherbrooke Capital POSCO BioVentures Novel Bioventures Alta Partners CDP Capital Technology Ventures | $27.6M |
| Series D, 4/07 Tudor Investments 3i Group Alta Partners CB Health Ventures Flagship Ventures POSCO BioVentures Sagamore Bioventures Sherbrooke Capital VantagePoint Capital Partners | $25.5M |
| Series E, 3/10 Foundation Capital Kleiner Perkins Caufield & Byers Flagship Ventures 3i Group Tudor Investments VantagePoint Capital Partners Sherbrooke Capital Alta Partners CB Health Ventures POSCO BioVentures Sagamore Bioventures | $36M |
| Venture Round, 8/11 | $6M |
| Venture Round, 11/12 | $36M |
| DEBT TOTAL | $6.07M |
| Debt, 7/09 | $2.5M |
| Debt, 11/09 | $3.57M |
Headquartered in Andover, Massachusetts, TransMedicsâ„¢ is a medical device company founded in 1998 to address the unmet need for better, more effective organ transplant technologies. The Company has developed the first commercial, portable warm blood perfusion system that allows for a new type of organ transplant, called a living organ transplant. This technology, called an Organ Care System, or OCS, is designed to maintain organs in a warm, functioning state outside of the body during transport from organ donor to recipient. The OCS could potentially increase organ availability and improve outcomes for the growing population of patients with end stage organ failure in need of a transplant, bridging the widening gap between the number of organs available and the number of recipients awaiting transplants.
